Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Early balding at 40 increases prostate cancer risk.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

CEC levels may be a useful marker for predicting prostate cancer progression.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Eating high-glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

DHT stops hair regrowth in mice, similar to human hair loss.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

A new compound was made that might help treat diseases related to male hormones.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Dosing time affects finasteride's effectiveness and safety in rats.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Gene variation affects prostate issues and hair loss.